West Virginia University’s Hematology/Oncology Fellowship Program is an intense, three-year experience that prepares its graduates by developing their clinical expertise in cancer therapy, guides them in acquiring the knowledge of basic biology of neoplastic diseases and teaches them to solve problems through research in Hematology-Oncology.
Trainees are introduced to Hematology/Oncology through clinical teaching on the wards and in clinics, as well as clinical and basic science lectures and conferences directed by faculty. Fellows also participate in clinical or laboratory research under faculty supervision.. Only a handful of students enter the program each year.
Center graduates of WVU’s Hematology/Oncology Fellowship Program. Ahsan Alamgir, Shamsher Ali and Marwan Shaikh were the guests of honor during a ceremony this past Wednesday in the atrium at the Mary Babb Randolph Cancer Center.
The WVU Cancer Institute is the first institution in the United States to offer intraoperative radiation therapy (IORT) to treat glioblastoma.
Several events at this year’s West Virginia Writers’ Workshop, July 20-23 at WVU, are focused on the role of writing and storytelling in health. Presenters include narrative medicine faculty from several campuses across the U.S., along with the leaders of an expressive writing program for patients at the WVU Cancer Institute. Health sciences faculty, staff and students are invited to participate in some or all of the Workshop.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.